Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Real-World Outcomes for Maintenance Treatment Sequencing after Receiving Lenalidomide, Bortezomib, and Dexamethasone Induction in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Followed By Autologous Stem Cell Transplant (ASCT)

Rafael Fonseca, MD, Kejal Parikh, BSPharm, MS, Brian Ung, PharmD, Quanhong Ni, MS, Safiya Abouzaid, MPH, PharmD, Amit Agarwal, MD PhD

Blood (2017) 130 (Supplement 1): 3463.

https://doi.org/10.1182/blood.V130.Suppl_1.3463.3463

Published: 2017

Journal Articles

Clinical and Economic Burden of Transfusion-Dependent β-Thalassemia in Adult Patients in the United States

Sujit Sheth, MD, Mia Weiss, BA, Monika Parisi, MPH, Quanhong Ni, MS

Blood (2017) 130 (Supplement 1): 2095.

https://doi.org/10.1182/blood.V130.Suppl_1.2095.2095

Published: 2017

Journal Articles

Lenalidomide Maintenance for Patients with Newly Diagnosed Multiple Myeloma Post Autologous Stem Cell Transplant: A Comparison of Real-World Treatment Outcomes and Costs

Parameswaran Hari, MD MRCP, MS, Brian Ung, PharmD, Safiya Abouzaid, MPH, PharmD, Quanhong Ni, MS, Kejal Parikh, BSPharm, MS, Amit Agarwal, MD PhD

Blood (2017) 130 (Supplement 1): 2189.

https://doi.org/10.1182/blood.V130.Suppl_1.2189.2189

Published: 2017

Journal Articles

Real-World Treatment Outcomes in Patients with Newly Diagnosed Multiple Myeloma Treated with Triplet Therapy without Stem Cell Transplant: An Enhanced Electronic Health Records Database

Ajai Chari, MD, Brian Ung, PharmD, Safiya Abouzaid, MPH, PharmD, Quanhong Ni, MS, Kejal Parikh, BSPharm, MS, Amit Agarwal, MD PhD

Blood (2017) 130 (Supplement 1): 2190.

https://doi.org/10.1182/blood.V130.Suppl_1.2190.2190

Published: 2017

Journal Articles

Females with Severe or Moderate Hemophilia A or B: A U.S. Study.

Donna M. DiMichele, MD, Constance B. Gibb, MS, Jacqueline M. Lefkowitz, MSW, Quanhong Ni, MS, Peter A. Kouides, MD, Linda M. Gerber, PhD

Blood (2007) 110 (11): 2146.

https://doi.org/10.1182/blood.V110.11.2146.2146

Published: 2007

NARROW

Real-World Outcomes for Maintenance Treatment Sequencing after Receiving Lenalidomide, Bortezomib, and Dexamethasone Induction in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Followed By Autologous Stem Cell Transplant (ASCT)

Clinical and Economic Burden of Transfusion-Dependent β-Thalassemia in Adult Patients in the United States

Lenalidomide Maintenance for Patients with Newly Diagnosed Multiple Myeloma Post Autologous Stem Cell Transplant: A Comparison of Real-World Treatment Outcomes and Costs

Real-World Treatment Outcomes in Patients with Newly Diagnosed Multiple Myeloma Treated with Triplet Therapy without Stem Cell Transplant: An Enhanced Electronic Health Records Database

Females with Severe or Moderate Hemophilia A or B: A U.S. Study.

Email alerts

ASH Publications

American Society of Hematology

Real-World Outcomes for Maintenance Treatment Sequencing after Receiving Lenalidomide, Bortezomib, and Dexamethasone Induction in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Followed By Autologous Stem Cell Transplant (ASCT)

Clinical and Economic Burden of Transfusion-Dependent β-Thalassemia in Adult Patients in the United States

Lenalidomide Maintenance for Patients with Newly Diagnosed Multiple Myeloma Post Autologous Stem Cell Transplant: A Comparison of Real-World Treatment Outcomes and Costs

Real-World Treatment Outcomes in Patients with Newly Diagnosed Multiple Myeloma Treated with Triplet Therapy without Stem Cell Transplant: An Enhanced Electronic Health Records Database

Females with Severe or Moderate Hemophilia A or B: A U.S. Study.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only